LONA

LeonaBio, Inc. - Common Stock (LONA)

About LeonaBio, Inc. - Common Stock (LONA)

LeonaBio, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Details

Daily high

$4.90

Daily low

$4.18

Price at open

$4.44

52 Week High

$14.21

52 Week Low

$2.21

Market cap

41.3M

Dividend yield

Volume

332,594

Avg. volume

469,710

P/E ratio

-.19

LeonaBio, Inc. - Common Stock News